University of Colorado, Hemophilia and Thrombosis Center

Aurora, Colorado 80045-7202

3 studies enrolling now · 9 studies all time

What they study most

Factor VII Deficiency, Glanzmann Thrombasthenia, Hemophilia A, Hemophilia A With Inhibitor, Hemophilia A With Inhibitors, Hemophilia A, Congenital, Hemophilia B, Hemophilia B With Inhibitors

Studies at this site

• A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A — Recruiting now
• A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A — Recruiting now
• A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B — Recruiting now
• A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy — Running, not enrolling
• Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A — Running, not enrolling
• Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis — Completed
• Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders — Stopped early
• Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors — Completed
• Inhibitor Development in Patients With Hemophilia A Undergoing Surgery — Completed